P
Paul Angulo
Researcher at University of Kentucky
Publications - 193
Citations - 35512
Paul Angulo is an academic researcher from University of Kentucky. The author has contributed to research in topics: Nonalcoholic fatty liver disease & Primary sclerosing cholangitis. The author has an hindex of 77, co-authored 191 publications receiving 32339 citations. Previous affiliations of Paul Angulo include Mayo Clinic & Durham University.
Papers
More filters
Journal ArticleDOI
The natural history of nonalcoholic fatty liver disease with advanced fibrosis or cirrhosis: an international collaborative study.
Neeraj Bhala,Neeraj Bhala,Neeraj Bhala,Paul Angulo,Paul Angulo,David van der Poorten,Eric Lee,Jason M. Hui,Giorgio Maria Saracco,Leon A. Adams,Leon A. Adams,Phunchai Charatcharoenwitthaya,Phunchai Charatcharoenwitthaya,Joanne H. Topping,Elisabetta Bugianesi,Christopher P. Day,Jacob George +16 more
TL;DR: Patients with NAFLD with advanced fibrosis or cirrhosis have lower rates of liver‐related complications and hepatocellular cancer than corresponding patients with HCV infection, but similar overall mortality.
Journal ArticleDOI
Betaine, a promising new agent for patients with nonalcoholic steatohepatitis: results of a pilot study
TL;DR: Betaine, a promising new agent for patients with nonalcoholic steatohepatitis, shows promising results in a pilot study.
Journal ArticleDOI
Lifestyle intervention and antioxidant therapy in children with nonalcoholic fatty liver disease: A randomized, controlled trial
Valerio Nobili,Melania Manco,Rita Devito,Vincenzo Di Ciommo,Donatella Comparcola,Maria Rita Sartorelli,Fiorella Piemonte,Matilde Marcellini,Paul Angulo +8 more
TL;DR: Lifestyle intervention with diet and increased physical activity induces weight loss and is associated with a significant improvement in liver histology and laboratory abnormalities in pediatric NAFLD, which does not seem to increase the efficacy of lifestyle intervention alone.
Journal ArticleDOI
Sarcopenic obesity and myosteatosis are associated with higher mortality in patients with cirrhosis.
Aldo J. Montano-Loza,Paul Angulo,Judith Meza-Junco,Carla M. Prado,Michael B. Sawyer,Crystal Beaumont,Nina Esfandiari,Mang Ma,Vickie E. Baracos +8 more
TL;DR: This study aimed to establish the frequency and clinical significance of sarcopenia, sarcopenic obesity and myosteatosis in cirrhotic patients.
Journal ArticleDOI
NAFLD in children: A prospective clinical-pathological study and effect of lifestyle advice
Valerio Nobili,Matilde Marcellini,Rita Devito,Paolo Ciampalini,Fiorella Piemonte,Donatella Comparcola,Maria Rita Sartorelli,Paul Angulo +7 more
TL;DR: It is concluded that children with NAFLD are almost always insulin‐resistant regardless of BMI, and obesity and older age are independently associated with increased liver fibrosis.